0001209191-23-035615.txt : 20230608 0001209191-23-035615.hdr.sgml : 20230608 20230608213344 ACCESSION NUMBER: 0001209191-23-035615 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230606 FILED AS OF DATE: 20230608 DATE AS OF CHANGE: 20230608 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wilson John Robert CENTRAL INDEX KEY: 0001755569 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37939 FILM NUMBER: 231003687 MAIL ADDRESS: STREET 1: 33 5TH AVENUE CITY: NEW BRIGHTON STATE: MN ZIP: 55112 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Marker Therapeutics, Inc. CENTRAL INDEX KEY: 0001094038 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 880277072 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4551 KENNEDY COMMERCE DR. CITY: HOUSTON STATE: TX ZIP: 77032 BUSINESS PHONE: (713) 400-6400 MAIL ADDRESS: STREET 1: 4551 KENNEDY COMMERCE DR. CITY: HOUSTON STATE: TX ZIP: 77032 FORMER COMPANY: FORMER CONFORMED NAME: TAPIMMUNE INC. DATE OF NAME CHANGE: 20170629 FORMER COMPANY: FORMER CONFORMED NAME: TAPIMMUNE INC DATE OF NAME CHANGE: 20070628 FORMER COMPANY: FORMER CONFORMED NAME: GENEMAX CORP DATE OF NAME CHANGE: 20020718 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-06 0 0001094038 Marker Therapeutics, Inc. MRKR 0001755569 Wilson John Robert C/O MARKER THERAPEUTICS, INC. 4551 KENNEDY COMMERCE DRIVE HOUSTON TX 77032 1 0 0 0 0 Stock Option (right to buy) 1.72 2023-06-06 4 A 0 8000 0.00 A 2033-06-05 Common Stock 8000 8000 D This option vests on June 6, 2024, subject to the Reporting Person's continued service as a director through the vesting date. /s/ Michael Loiacono, Attorney-in-Fact 2023-06-08